Name: WST Income Statement - West Pharmaceutical Services Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

WST - West Pharmaceutical Services Inc.

USD | NYSE | Healthcare

WST Income Statement - West Pharmaceutical Services Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	844.9	805.0	804.6	766.5	698.0	748.8	746.9	702.1	695.4	732.0	747.4	753.8	716.6	708.7	686.9	771.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	3,221.0	3,074.1	2,893.2	2,949.8	2,886.9	2,831.6	2,146.9	1,839.9	1,717.4	1,599.1	1,509.1	1,399.8	1,421.4	1,368.4	1,266.4	1,192.3	1,104.7	1,055.7
Cost of Revenue	2,052.5	1,970.1	1,894.7	1,820.6	1,750.7	1,655.8	1,379.1	1,234.2	1,172.0	1,086.2	1,007.7	944.0	973.6	933.7	878.7	853.0	786.6	752.1
Gross Profit	1,168.5	1,104.0	998.5	1,129.2	1,136.2	1,175.8	767.8	605.7	545.4	512.9	501.4	455.8	447.8	434.7	387.7	339.3
Operating Expenses
Research & Development	73.8	74.3	69.1	68.4	58.5	52.8	46.9	38.9	40.3	39.1	36.8	34.1	37.3	37.9	33.2
Operating Income
Operating Income	655.0	584.9	569.9	676.0	734.0	752.3	406.9	296.6	240.3	225.8	195.2	128.6	182.0	162.4
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax & Net
Income Tax Expense	142.2	121.6	107.5	122.3	114.7	107.2	72.5	59.0	41.4	80.9	54.4	26.3	47.2	40.2	32.7
Per Share
EPS Basic	7.54	6.83	6.75	7.98	7.87	8.89	4.68	3.27	2.80	2.04	1.96	1.33	1.79	1.61	1.19	1.12
Supplementary Data
EBITDA	831.6	756.3	725.3	813.3	854.6	874.6	516.0	400.0	344.7	322.5	285.9	218.5	272.0	247.6	212.0	185.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	15.8	21.8	17.1	19.1	16.3	18.5	15.5	17.5	17.6	18.4	16.4	16.5	17.1	15.9	13.6	14.4	14.6	13.7	13.1	13.8	12.2	12.9	12.5	10.8	10.7	10.2	9.3	9.6	9.8	9.8	10.1	10.8	9.6	9.7	9.1	10.0	10.3	9.6	9.0	8.8
Selling General & Administrative	99.5	107.0	102.7	95.9	88.0	85.3	83.5	83.0	86.7	90.0	89.0	88.4	86.0	85.7	66.3	81.5
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	45.2	47.0	43.0	41.4	40.0	40.7	40.2	38.9	35.6	-	-	-	30.7	-	-	-
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.2
Other Operating Expenses	0.0	(0.3)	(0.3)	(0.3)	(0.4)	0.0	(0.6)	0.0	(0.3)	(1.0)	0.4	(0.3)	(0.4)	1.7	0.3	0.1	0.0
Total Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Operating Income
Operating Income	177.1	156.6	167.6	153.7	107.0	159.6	161.3	126.2	122.8	160.9	177.3	182.5	155.3	129.7	186.2	228.4	189.7	184.0	181.4	211.3	175.6	116.1	99.2	103.6	88.0	78.1	67.3	80.5	70.7	65.8	60.8	60.3	53.4	60.4	62.9	42.0	60.5	52.7	51.3	61.2

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	1.9	(0.2)	0.2	0.1	0.4	(0.8)	0.7	1.5	1.6	1.2	2.9	2.7	2.2	1.7	2.2	1.8	2.2	2.6
Income From Equity Investments	3.4	3.9	2.1	5.0	3.4	2.0	3.9	4.5	4.3	3.3	3.7	5.0	5.7	3.2	4.8	5.5
Other Non-Operating Income	(0.2)	(0.4)	(0.2)	(0.2)	(0.2)	(11.3)	3.2	2.5	4.6	7.3	9.7	2.4	2.6	(1.0)	(50.0)	(1.2)	(1.9)
Pre-Tax Income	180.1	161.5	171.9	157.0	110.5	164.9	164.5	128.7	127.4	168.2	187.0	184.9	157.9	128.7	136.2	227.2

Tax & Net
Income Tax Expense	44.7	33.3	34.0	30.2	24.1	36.8	32.4	21.9	16.4	34.5	29.4	34.8	23.6	28.9	20.4	44.2	21.2	34.2	12.0	32.3	28.7	20.4	21.1	16.0	15.0	16.5	10.9	15.5	16.1	14.9	8.0	6.0	12.5	61.8	14.0	2.9	2.2	16.1	14.4	17.0
Net Income From Continuing Ops	138.8	132.1	140.0	131.8	89.8	130.1	136.0	111.3	115.3	137.0	161.3	155.1	140.0	103.0	120.6	188.5	173.8
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	138.8	132.1	140.0	131.8	89.8	130.1	136.0	111.3	115.3	137.0	161.3	155.1	140.0	103.0	120.6	188.5	173.8
Net Income Attributable To Parent	138.8	132.1	140.0	131.8	89.8	130.1	136.0	111.3	115.3	137.0	161.3	155.1	140.0	103.0	120.6	188.5
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	138.8	132.1	140.0	131.8	89.8	130.1	136.0	111.3	115.3	137.0	161.3	155.1	140.0	103.0	120.6

Per Share
EPS Basic	1.93	-	1.94	1.82	1.24	-	1.87	1.52	1.57	-	2.17	2.08	1.88	-	1.62	2.53	2.34	-	2.37	2.53	2.04	-	1.11	1.24	1.01	-	0.76	0.90	0.75	-	0.75	0.76	0.59	-	0.69	0.53	0.83	-	0.51	0.61
EPS Diluted	1.92	-	1.92	1.82	1.23	-	1.85	1.51	1.55	-	2.14	2.06	1.85	-	1.59	2.48	2.29	-
Shares Basic	72.0	-	72.2	72.2	72.5	-	72.8	73.0	73.5	-	74.3	74.3	74.5	-	74.4	74.4	74.4	-
Shares Diluted	72.4	-	72.6	72.5	73.0	-	73.4	73.7	74.3	-	75.3	75.4	75.7	-	75.7	75.8	76.0	-

Supplementary Data
EBITDA	222.3	203.6	210.6	195.1	147.0	200.3	201.5	165.1	158.4	-	-	-	186.0	-	-	-	218.4	-	-	-	203.6	-	-	-	112.9	-	-	-	95.6	-	-	-	79.1	-	-	-	83.1	-	-	-
EBIT	177.1	156.6	167.6	153.7	107.0	159.6	161.3	126.2	122.8	160.9	177.3	182.5	155.3	129.7	186.2	228.4	189.7	184.0	181.4